Tapewire

Nasdaq · USD

TMDX

TransMedics Group, Inc.

Export transactions ↓
Tapewire entity
4261
SEC CIK
0001756262
Parsed reports
356

Last 12 months

Inside the activity.

2 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202511
Dec 202502
Jan 202600
Feb 202600
Mar 202607
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 04, 2025 Filed Aug 5, 2025 20:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,143 Not disclosed Strike: $0.70 Not disclosed
Disclosure

SEC source: 0000950170-25-103110 · ownership.xml · derivative · entry 3

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,142

Underlying: Common Stock · 4,143 shares

Expires 2026-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F1 · derivative.exercise_date: The option is fully vested.

Read SEC document
August 04, 2025 Filed Aug 5, 2025 20:30 UTC SaleCommon Stock 4,143 $125.51 $519,987.93
Disclosure

SEC source: 0000950170-25-103110 · ownership.xml · nonDerivative · entry 2

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,866

Read SEC document
August 04, 2025 Filed Aug 5, 2025 20:30 UTC Exercise / conversionCommon Stock 4,143 $0.70 $2,900.10
Disclosure

SEC source: 0000950170-25-103110 · ownership.xml · nonDerivative · entry 1

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 09, 2025 Filed Jun 10, 2025 20:44 UTC SaleCommon Stock 686 $139.80 $95,902.80
Disclosure

SEC source: 0000950170-25-084405 · ownership.xml · nonDerivative · entry 1

Ranganath Anil P. · CIK 0001980144 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,955

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

Read SEC document
May 27, 2025 Filed May 29, 2025 20:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 Not disclosed Strike: $0.70 Not disclosed
Disclosure

SEC source: 0000950170-25-079022 · ownership.xml · derivative · entry 3

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,285

Underlying: Common Stock · 5,000 shares

Expires 2026-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F1 · derivative.exercise_date: The option is fully vested.

Read SEC document
May 27, 2025 Filed May 29, 2025 20:30 UTC SaleCommon Stock 5,000 $126.45 $632,250.00
Disclosure

SEC source: 0000950170-25-079022 · ownership.xml · nonDerivative · entry 2

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,866

Read SEC document
May 27, 2025 Filed May 29, 2025 20:30 UTC Exercise / conversionCommon Stock 5,000 $0.70 $3,500.00
Disclosure

SEC source: 0000950170-25-079022 · ownership.xml · nonDerivative · entry 1

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 23, 2025 Filed May 23, 2025 22:41 UTC
Weill DavidDirector
SaleCommon Stock 732 $123.88 $90,680.16
Disclosure

SEC source: 0000950170-25-077211 · ownership.xml · nonDerivative · entry 2

Weill David · CIK 0001774270 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,134

Read SEC document
May 22, 2025 Filed May 23, 2025 22:46 UTC GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077220 · ownership.xml · nonDerivative · entry 1

RAINES MERILEE · CIK 0001023869 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,059

F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 22, 2025 Filed May 23, 2025 22:47 UTC GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077221 · ownership.xml · nonDerivative · entry 1

TOBIN JAMES R · CIK 0001190128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,059

F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 22, 2025 Filed May 23, 2025 22:43 UTC
Kania EdwinDirector
GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077213 · ownership.xml · nonDerivative · entry 1

KANIA EDWIN M JR · CIK 0001255927 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,810

F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 22, 2025 Filed May 23, 2025 22:45 UTC GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077216 · ownership.xml · nonDerivative · entry 1

Gunderson Thomas James · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,059

F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 22, 2025 Filed May 23, 2025 22:48 UTC GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077227 · ownership.xml · nonDerivative · entry 1

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,866

F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 22, 2025 Filed May 23, 2025 22:48 UTC GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077225 · ownership.xml · nonDerivative · entry 1

Lovell Stephanie · CIK 0001772054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,059

F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 22, 2025 Filed May 23, 2025 22:41 UTC
Weill DavidDirector
GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077211 · ownership.xml · nonDerivative · entry 1

Weill David · CIK 0001774270 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,866

F1 · shares: Consists of 2,134 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 09, 2025 Filed May 13, 2025 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 Not disclosed Strike: $0.70 Not disclosed
Disclosure

SEC source: 0000950170-25-070568 · ownership.xml · derivative · entry 3

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,285

Underlying: Common Stock · 6,000 shares

Expires 2026-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F1 · derivative.exercise_date: The option is fully vested.

Read SEC document
May 09, 2025 Filed May 13, 2025 21:43 UTC SaleCommon Stock 6,000 $115.63 $693,780.00
Disclosure

SEC source: 0000950170-25-070568 · ownership.xml · nonDerivative · entry 2

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 732

Read SEC document
May 09, 2025 Filed May 13, 2025 21:43 UTC Exercise / conversionCommon Stock 6,000 $0.70 $4,200.00
Disclosure

SEC source: 0000950170-25-070568 · ownership.xml · nonDerivative · entry 1

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 16:30 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 2,407 $76.43 $183,967.01
Disclosure

SEC source: 0000950170-25-033706 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,042

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 23:16 UTC
Hassanein Waleed HDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 90,185 $0.00 Strike: $73.00 $0.00
Disclosure

SEC source: 0000950170-25-028069 · ownership.xml · derivative · entry 3

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,185

Underlying: Common Stock · 90,185 shares

Expires 2035-02-25

F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 25, 2025 until the option is fully vested on February 25, 2029, subject to continued service.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 23:16 UTC
Hassanein Waleed HDirector · President & CEO
GrantCommon Stock 59,781 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-028069 · ownership.xml · nonDerivative · entry 1

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,424

F1 · shares: Consists of 59,781 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 23:15 UTC
Hernandez GerardoChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 5,299 $0.00 Strike: $77.12 $0.00
Disclosure

SEC source: 0000950170-25-028063 · ownership.xml · derivative · entry 2

Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,299

Underlying: Common Stock · 5,299 shares

Expires 2035-02-24

F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 23:15 UTC
Hernandez GerardoChief Financial Officer
GrantCommon Stock 3,521 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-028063 · ownership.xml · nonDerivative · entry 1

Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,984

F1 · shares: Consists of 3,521 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 18:07 UTC
Khayal Tamer IChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 26,499 $0.00 Strike: $77.12 $0.00
Disclosure

SEC source: 0000950170-25-028040 · ownership.xml · derivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,499

Underlying: Common Stock · 26,499 shares

Expires 2035-02-24

F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 18:07 UTC
Khayal Tamer IChief Commercial Officer
GrantCommon Stock 17,606 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-028040 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,449

F1 · shares: Consists of 17,606 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 23:12 UTC GrantStock Option (Right to Buy) · Derivative 19,079 $0.00 Strike: $77.12 $0.00
Disclosure

SEC source: 0000950170-25-028054 · ownership.xml · derivative · entry 2

Corcoran Nicholas · CIK 0001964148 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,079

Underlying: Common Stock · 19,079 shares

Expires 2035-02-24

F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 23:12 UTC GrantCommon Stock 12,676 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-028054 · ownership.xml · nonDerivative · entry 1

Corcoran Nicholas · CIK 0001964148 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,781

F1 · shares: Consists of 12,676 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 23:09 UTC GrantStock Option (Right to Buy) · Derivative 8,479 $0.00 Strike: $77.12 $0.00
Disclosure

SEC source: 0000950170-25-028048 · ownership.xml · derivative · entry 2

Ranganath Anil P. · CIK 0001980144 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,479

Underlying: Common Stock · 8,479 shares

Expires 2035-02-24

F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 23:09 UTC GrantCommon Stock 5,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-028048 · ownership.xml · nonDerivative · entry 1

Ranganath Anil P. · CIK 0001980144 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,641

F1 · shares: Consists of 5,634 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 114 shares of Issuer's Common Stock acquired on December 31, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of July 1, 2024 to December 31, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2024.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 16:29 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,083 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-25-004192 · ownership.xml · derivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,167

Underlying: Common Stock · 1,083 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 16:29 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 1,083 $80.05 $86,694.15
Disclosure

SEC source: 0000950170-25-004192 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,843

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 16:29 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 1,083 $13.28 $14,382.24
Disclosure

SEC source: 0000950170-25-004192 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
December 09, 2024 Filed Dec 11, 2024 23:48 UTC
Hernandez GerardoChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 18,922 $0.00 Strike: $69.84 $0.00
Disclosure

SEC source: 0000950170-24-135528 · ownership.xml · derivative · entry 2

Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,922

Underlying: Common Stock · 18,922 shares

Expires 2034-12-09

F2 · derivative.exercise_date: The option vests as to 25% of the shares underlying the option on December 2, 2025 and as to the remaining shares in equal monthly installments over three years thereafter, subject to Reporting Persons' continued service to the Issuer.

Read SEC document
December 09, 2024 Filed Dec 11, 2024 23:48 UTC
Hernandez GerardoChief Financial Officer
GrantCommon Stock 12,463 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-135528 · ownership.xml · nonDerivative · entry 1

Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,463

F1 · shares: Consists of 12,463 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 18:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,084 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-24-133392 · ownership.xml · derivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,250

Underlying: Common Stock · 1,084 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 18:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 1,084 $86.40 $93,657.60
Disclosure

SEC source: 0000950170-24-133392 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,843

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $86.21 to $86.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 18:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 1,084 $13.28 $14,395.52
Disclosure

SEC source: 0000950170-24-133392 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 16:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,458 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000950170-24-126397 · ownership.xml · derivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,834

Underlying: Common Stock · 1,458 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 16:30 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 1,458 $90.04 $131,278.32
Disclosure

SEC source: 0000950170-24-126397 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,843

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 16:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 1,458 $38.46 $56,074.68
Disclosure

SEC source: 0000950170-24-126397 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,750 $0.00 Strike: $28.12 $0.00
Disclosure

SEC source: 0000950170-24-123425 · ownership.xml · derivative · entry 4

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,750 shares

Expires 2032-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · derivative.exercise_date: The option is fully vested.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:30 UTC SaleCommon Stock 1,454 $84.30 $122,572.20
Disclosure

SEC source: 0000950170-24-123425 · ownership.xml · nonDerivative · entry 3

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 732

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.00 to $84.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:30 UTC SaleCommon Stock 5,296 $83.35 $441,421.60
Disclosure

SEC source: 0000950170-24-123425 · ownership.xml · nonDerivative · entry 2

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,186

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.91 to $83.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:30 UTC Exercise / conversionCommon Stock 6,750 $28.12 $189,810.00
Disclosure

SEC source: 0000950170-24-123425 · ownership.xml · nonDerivative · entry 1

Basile Edward M · CIK 0001773661 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 16:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,083 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-24-121525 · ownership.xml · derivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,334

Underlying: Common Stock · 1,083 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 16:30 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 1,083 $82.64 $89,499.12
Disclosure

SEC source: 0000950170-24-121525 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,843

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.55 to $82.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 16:30 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 1,083 $13.28 $14,382.24
Disclosure

SEC source: 0000950170-24-121525 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:30 UTC
Hassanein Waleed HDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 8,625 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-24-115332 · ownership.xml · derivative · entry 7

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,250

Underlying: Common Stock · 8,625 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:30 UTC
Hassanein Waleed HDirector · President & CEO
SaleCommon Stock 300 $135.04 $40,512.00
Disclosure

SEC source: 0000950170-24-115332 · ownership.xml · nonDerivative · entry 5

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,643

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $134.63 to $135.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:30 UTC
Hassanein Waleed HDirector · President & CEO
SaleCommon Stock 1,200 $134.23 $161,076.00
Disclosure

SEC source: 0000950170-24-115332 · ownership.xml · nonDerivative · entry 4

Hassanein Waleed H · CIK 0001430466 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,943

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $133.57 to $134.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.